Tri Locum Partners LP: holdings and changes
Number 83 of the top 100 funds by copy return. Tri Locum Partners LP reported 18 US stocks worth $506M for the quarter ending 2026-09-30 and changed 3 new, 2 added, 13 trimmed and 4 sold since 2026-06-30.
Copy return, 4 quarters+37.1%
US 500, same time+14.5%
Size$506M
Stocks18
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals INC Com | TRIM -34% | 13.73% | $70M | 132,896 |
| LLY Eli Lilly & Co | TRIM -33% | 11.66% | $59M | 51,015 |
| TEVA Teva Pharm Inds LTD Adrf Spons | ADD +64% | 9.57% | $48M | 1,223,725 |
| AMRX Amneal Pharmaceuticals INC | BUY | 9.26% | $47M | 2,326,733 |
| DXCM Dexcom INC | TRIM -40% | 8.34% | $42M | 489,400 |
| JAZZ Jazz Pharmaceuticals | TRIM -28% | 7.33% | $37M | 160,321 |
| ARGX Argenx Se | TRIM -27% | 5.76% | $29M | 30,399 |
| ASND Ascendis Pharma A/S | TRIM -54% | 5.33% | $27M | 118,384 |
| AXSM Axsome Therapeutics INC | TRIM -35% | 5.22% | $26M | 143,338 |
| JNJ Johnson & Johnson | TRIM -83% | 3.85% | $20M | 73,559 |
| ELVN Enliven Therapeutics INC | TRIM -53% | 3.72% | $19M | 410,236 |
| UTHR United Therapeutics Corp | TRIM -30% | 3.53% | $18M | 33,000 |
| MDGL Madrigal Pharmaceuticals INC | TRIM -51% | 3.35% | $17M | 33,668 |
| CELC Celcuity INC | BUY | 3.18% | $16M | 202,618 |
| DNTH Dianthus Therapeutics INC | ADD +47% | 3.08% | $16M | 177,225 |
| RVMD Revolution Medicines INC | TRIM -74% | 1.62% | $8M | 40,019 |
| DFTX Definium Therapeutics INC | TRIM -11% | 1.09% | $6M | 144,406 |
| VRDN Viridian Therapeutics INC | BUY | 0.37% | $2M | 90,107 |
| TARS Tarsus Pharmaceuticals INC | SELL | 0% | was $21M | 0 |
| ISRG Intuitive Surgical INC | SELL | 0% | was $19M | 0 |
| CYTK Cytokinetics INC. | SELL | 0% | was $16M | 0 |
| BBNX Beta Bionics INC | SELL | 0% | was $8M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2021-06-30 → 2021-09-30 | -0.2% | +0.3% |
| 2022-12-31 → 2023-03-31 | +0.5% | +7.0% |
| 2023-06-30 → 2023-09-30 | -6.0% | -3.6% |
| 2023-12-31 → 2024-03-31 | +16.5% | +10.0% |
| 2024-09-30 → 2024-12-31 | -1.8% | +2.1% |
| 2024-12-31 → 2025-03-31 | -12.0% | -4.6% |
| 2025-03-31 → 2025-06-30 | -0.1% | +10.5% |
| 2025-09-30 → 2025-12-31 | +16.1% | +2.4% |
| 2025-12-31 → 2026-03-31 | +4.1% | -4.6% |
| 2026-03-31 → 2026-06-30 | +8.3% | +14.8% |
| 2026-06-30 → 2026-09-30 | +4.8% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP